Doctor profile · Federal record
Dr. Saro Sarkisian, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hospitalist Physician · Frederick, MD
- NPI 1164735387
- Accepts Medicare
- 17 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
1562 Opossumtown Pike
Frederick, MD 217024920
(301) 662-8477 - Additional location
-
1240 S Cedar Crest Blvd Ste 401
Allentown, PA 18103
(788) 061-0402 - Mailing address
-
Po Box 37086
Baltimore, MD 212973086
Credentials & registration
- NPI registered
- July 2010 — 16 yrs on file
- Profile last updated
- July 21, 2021
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Maryland #D0090258 · Pennsylvania #MD449103
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164735387. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
81,395
Distinct HCPCS
10
Medicare allowed
$1,443,021
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9271 |
Injection, pembrolizumab, 1 mg | 15,000 | 31 | $44 | |
J1453 |
Injection, fosaprepitant, 1 mg | 12,000 | 33 | $0 | |
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 10,710 | 16 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 9,420 | 88 | $22 | |
J9263 |
Injection, oxaliplatin, 0.5 mg | 8,880 | 12 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 5,350 | 17 | $0 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 4,440 | 11 | $3 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,440 | 13 | $45 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 2,770 | 13 | $28 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,040 | 83 | $0 |
In context: peer comparison
Among 4 peers in Frederick Hematology & Oncology Physician, average services per provider: 2,076. This provider delivers 39× the peer median.Open Payments
Industry payments received
All-time total
$20,227
Transactions
27
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US INC | 11 | $17,529.56 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $2,112.56 | |
| AstraZeneca Pharmaceuticals Lp | 4 | $156.16 | |
| Tempus Ai, INC | 3 | $154.61 | |
| Regeneron Healthcare Solutions, INC. | 1 | $100.68 | |
| AngioDynamics, INC. | 1 | $95.23 | |
| Janssen Biotech, INC. | 1 | $34.88 | |
| Daiichi Sankyo INC. | 1 | $22.15 | |
| Bayer Healthcare Pharmaceuticals INC. | 1 | $21.02 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
436
Patients
70
Total drug cost
$1,554,894
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 78 | 18 | $59,332 |
| Prednisone | Generic | 37 | 12 | $185 |
| Anastrozole | Generic | 35 | 0 | $897 |
| Xarelto (Rivaroxaban) | Brand | 35 | 0 | $27,582 |
| Acyclovir | Generic | 27 | 0 | $420 |
| Dexamethasone | Generic | 25 | 17 | $1,166 |
| Gabapentin | Generic | 25 | 0 | $192 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 25 | 0 | $518,711 |
| Letrozole | Generic | 25 | 0 | $359 |
| Ondansetron Hcl | Generic | 25 | 23 | $297 |
Hospital affiliations
Frequently asked questions
What is Dr. Saro Sarkisian's medical specialty?
Dr. Saro Sarkisian practices Hematology & Oncology Physician in Frederick, MD.
Where does Dr. Saro Sarkisian practice?
Dr. Saro Sarkisian practices at 1562 Opossumtown Pike, Frederick, MD 217024920. Office phone: 3016628477.
What is Dr. Saro Sarkisian's NPI?
Dr. Saro Sarkisian's National Provider Identifier (NPI) is 1164735387, issued by NPPES.
Does Dr. Saro Sarkisian accept Medicare assignment?
Yes. Dr. Saro Sarkisian accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Saro Sarkisian commonly perform?
Top Medicare-reported procedures in 2023: Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138). Source: CMS Medicare Physician & Other Practitioners file.